|
US6025154A
(en)
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
IL129164A
(en)
|
1996-09-26 |
2007-05-15 |
Chugai Pharmaceutical Co Ltd |
An antibody against peptides associated with human parathyroid hormone
|
|
SE9801098D0
(sv)
*
|
1998-03-30 |
1998-03-30 |
Astra Pharma Prod |
Receptors
|
|
US6575118B1
(en)
*
|
1998-05-07 |
2003-06-10 |
Mckee William Douglas |
Valve assembly
|
|
US6171590B1
(en)
*
|
1998-09-30 |
2001-01-09 |
Corixa Corporation |
Chemokine receptor peptide for inducing an immune response
|
|
WO2000028028A1
(en)
*
|
1998-11-06 |
2000-05-18 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
|
|
US6329159B1
(en)
*
|
1999-03-11 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
|
|
US6358697B2
(en)
*
|
1999-04-21 |
2002-03-19 |
Children's Hospital Medical Center |
Intracellular pharmaceutical targeting
|
|
EP1208196B1
(en)
|
1999-08-03 |
2006-10-18 |
Millennium Pharmaceuticals, Inc. |
15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
|
|
JP2003516324A
(ja)
*
|
1999-11-24 |
2003-05-13 |
シェーリング コーポレイション |
転移を阻害する方法
|
|
US6949243B1
(en)
|
1999-11-24 |
2005-09-27 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
AU2001249546A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Corixa Corporation |
Methods for treating disease with antibodies to cxcr3
|
|
EP1987842A1
(en)
|
2000-04-28 |
2008-11-05 |
Chugai Seiyaku Kabushiki Kaisha |
Cell proliferation inhibitor
|
|
US7052676B2
(en)
|
2000-09-26 |
2006-05-30 |
The Regents Of The University Of Michigan |
Methods for inhibition of HIV replication using a small molecule inhibitor
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
EP1411966A4
(en)
*
|
2001-07-12 |
2005-06-01 |
Univ California |
METHOD FOR TREATING SECONDARY TISSUE ENERGY IN CONNECTION WITH DAMAGE TO THE CENTRAL NERVOUS SYSTEM
|
|
US7442512B2
(en)
|
2001-11-30 |
2008-10-28 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7413866B2
(en)
|
2001-11-30 |
2008-08-19 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7253007B2
(en)
|
2001-11-30 |
2007-08-07 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7393934B2
(en)
|
2001-12-21 |
2008-07-01 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor (CCR5) HDGNR10
|
|
WO2003072134A1
(fr)
*
|
2002-02-28 |
2003-09-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Diagnostics et therapeutiques pour la pneumonie interstitielle
|
|
WO2003082335A1
(fr)
*
|
2002-04-03 |
2003-10-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Nouveau dispositif de controle du sucre dans le sang et procede de criblage associe
|
|
NZ566263A
(en)
|
2002-05-24 |
2009-09-25 |
Millennium Pharm Inc |
CCR9 inhibitors and methods of use thereof
|
|
ATE363470T1
(de)
|
2002-11-18 |
2007-06-15 |
Chemocentryx Inc |
Arylsulfonamide
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
US7227035B2
(en)
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
MXPA05006507A
(es)
|
2002-12-20 |
2006-02-17 |
Chemocentryx |
Inhibidores de ccxckr2 expresado en tumor humano.
|
|
US7834155B2
(en)
|
2003-07-21 |
2010-11-16 |
Immunogen Inc. |
CA6 antigen-specific cytotoxic conjugate and methods of using the same
|
|
EP1631315B1
(en)
*
|
2003-09-24 |
2014-07-30 |
Millennium Pharmaceuticals, Inc. |
Antibodies which bind human cxcr3
|
|
AU2005219322B2
(en)
*
|
2004-03-09 |
2008-09-18 |
Kyoto University |
Pharmaceutical Composition Comprising CXCR3 Inhibitor
|
|
JP2008507255A
(ja)
|
2004-03-12 |
2008-03-13 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
ヒトｇタンパク質ケモカインレセプター（ｃｃｒ５）ｈｄｇｎｒ１０
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
CN101163718B
(zh)
|
2005-04-21 |
2012-10-10 |
凯莫森特里克斯股份有限公司 |
结合ccx-ckr2的试剂
|
|
CA3009680C
(en)
|
2006-03-16 |
2023-08-15 |
Symthera Canada Ltd. |
Combination of cytokine and cytokine receptor for altering immune system functioning
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
US8435522B2
(en)
*
|
2007-02-01 |
2013-05-07 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against CXCR3
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
PL2175859T3
(pl)
|
2007-07-12 |
2012-09-28 |
Chemocentryx Inc |
Skondensowane heteroarylopirydylo- i fenylo-benzenosulfonamidy jako modulatory CCR2 do leczenia zapalenia
|
|
CA2862222A1
(en)
*
|
2012-01-20 |
2013-07-25 |
Genzyme Corporation |
Anti-cxcr3 antibodies
|
|
EP2866830A4
(en)
*
|
2012-06-27 |
2015-12-09 |
Jyant Technologies |
ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR THE INHIBITION OF INFLAMMATION
|
|
US9681647B2
(en)
|
2012-07-05 |
2017-06-20 |
Cornell University |
Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
|
|
WO2014186842A1
(en)
*
|
2013-05-22 |
2014-11-27 |
Monash University |
Antibodies and uses thereof
|
|
IL294410B2
(en)
|
2016-11-23 |
2024-02-01 |
Chemocentryx Inc |
Method of treating focal segmental glomerulosclerosis
|
|
EP3551047A1
(en)
|
2016-12-07 |
2019-10-16 |
Progenity, Inc. |
Gastrointestinal tract detection methods, devices and systems
|
|
CA3045310A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
|
CN111417389A
(zh)
|
2017-10-11 |
2020-07-14 |
坎莫森特里克斯公司 |
Ccr2拮抗剂对局灶性节段性肾小球硬化症的治疗
|
|
CN116726362A
(zh)
|
2018-11-19 |
2023-09-12 |
比奥拉治疗股份有限公司 |
用生物治疗剂治疗疾病的方法和装置
|
|
CN115666704B
(zh)
|
2019-12-13 |
2025-09-26 |
比特比德科有限责任公司 |
用于将治疗剂递送至胃肠道的可摄取装置
|
|
EP4277924A2
(en)
*
|
2021-01-12 |
2023-11-22 |
Charité - Universitätsmedizin Berlin |
A cxcr3+ cell or cell preparation for use in cancer treatment
|